Prevention and Treatment of Cancer is the Most Significant Topic of the 21st Century
In 2018, there were 18 million reported cancer cases worldwide. This month, our Quiet Heroes behind the scenes at Eurofins Central Laboratory stand with the Leukemia & Lymphoma Society in recognizing September as Blood Cancer Awareness Month. Some of these cancers include:
Read More
Tags:
Central Laboratory,
Quality,
Clinical Trial,
Drug Development,
Development,
BioPharma,
Cancer,
Blood Cancer
The largest internal organ in the human body is the liver. The liver aids in digestion, energy storage, removal of toxins from the body, and supports many other functions. Because of the important job requirements set forth for this internal organ, evolution has assured us complete regeneration, so long as 25% of the tissue remaining is healthy.
Read More
Tags:
Central Laboratory,
Clinical Trial,
Drug Development,
Bioanalytical Testing,
Development,
BioPharma,
Liver,
Hepatitis
Eurofins BioPharma Services will be attending the DIA Global Annual Meeting in San Diego, CA, June 23-27! Join us at Booth 1705 to discover how our dedicated BioPharma laboratories provide seamless, end-to-end solutions to help customers progress through the drug development cycle through a single, experienced provider!
Read More
Tags:
Central Laboratory,
Quality,
Clinical Trial,
Drug Development,
Development,
BioPharma,
Gene Therapy
For the 2019 CRO Leadership Awards, Life Science Leader magazine once again teamed up with Industry Standard Research (ISR) to determine the award recipients. More than 60 contract research organizations were assessed on over 20 performance metrics in ISR's annual CRO Quality Benchmarking survey. Eurofins is recognized as a recipient of these awards, exceeding customer expectations in every category.
Read More
Tags:
Central Laboratory,
Quality,
Results,
Drug Development,
Development,
BioPharma
Eurofins BioPharma Services will be attending the 2019 BIO International Convention in Philadelphia, June 3-6, to celebrate the globally important innovations in biotech that start with one: one meeting, one theory, one trial, one breakthrough. Join Eurofins BioPharma Services at Booth 2949 to consider how the largest wholly-owned network of BioPharma dedicated laboratories in the world can assist in your clinical trial research!
Read More
Tags:
Central Laboratory,
Quality,
Results,
Clinical Trial,
BioPharma
Today, on March 8th, 2019, Eurofins Central Laboratory, a member of Eurofins BioPharma Services, celebrates International Women's Day (IWD).
Read More
Tags:
Central Laboratory,
Quality,
Results,
Peace,
Development,
BioPharma,
Leadership,
International Women's Day
In 2017, China became the world's second-largest national pharmaceutical market, due to its aging population and rising medical needs. In its ongoing commitment to adapt to emerging trends in the pharmaceutical industry, Eurofins Central Laboratory, a member of Eurofins BioPharma Services, has expanded its facility in Shanghai, China.
Read More
Tags:
Central Laboratory,
Clinical Trial,
Development,
Science Education,
Shanghai
Today, at all four of our wholly-owned central laboratory testing facilities (United States, Netherlands, China, and Singapore), we at Eurofins Central Laboratory, a division of Eurofins BioPharma Services, wear red with the American Heart Association to aide in uniting the world from continent to continent in effort of bringing awareness to our friends, families, and colleagues suffering from cardiovascular-related diseases (CVD). Diseases under this remit include, but are not limited to, defects at birth, heart rhythm complications, and abnormal blood vessel conditions.
Read More
Tags:
Quality,
Results,
Development,
American Heart Month,
Heart Disease,
Healthy Lifestyle
On January 27th, Eurofins Central Laboratory recognizes World Leprosy Day with the World Health Organization (WHO). Also known as Hansen’s disease, Leprosy is a chronic infectious disease caused by Mycobacterium Leprae. This disease affects the skin, peripheral nerves, mucus membranes of the upper respiratory tract, and eyes. Individuals affected will experience sensory loss in these affected areas as well as damaged thickened nerves.
Read More
Tags:
Central Laboratory,
Drug Development,
Bioanalytical Testing,
BioPharma,
Leprosy